ICER Turns Attention to Health Insurers — New Report Will Examine Whether Plans Provide ‘Fair Access’ to Drugs

On May 12, 2021, the Institute for Clinical and Economic Review (ICER or the Institute) released plans to begin an annual examination into health insurance drug coverage policies to assess “fair access” to prescription drugs. The purpose of the examination and resulting report is to promote dialogue with regard to whether “insurers are providing appropriate access for drugs that have been responsibly priced.”...
By: Faegre Drinker Biddle & Reath LLP

Array